Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(99)
•••
Comment by HaulJockeyon Jul 05, 2019 11:26am
107 Views
Post# 29889658

RE:Hello.., what's this?

RE:Hello.., what's this?
HaulJockey wrote: Did they say Argentina? Oh my, I think Aphria has that covered!

Link



Founded in 2007, Aphria Inc.’s wholly-owned subsidiary, ABP, is an established pharmaceutical import and distribution company that was granted the first Argentina Ministry of Health permit for the import of pharmaceutical-grade medical cannabis. ABP distributes to an extensive network of pharmacies, distributors, government clinics and hospitals throughout Argentina. ABP is focused on the research and clinical study of medical cannabis, including its partnership with Hospital de Pediatria Garrahan, a leading pediatric hospital in Buenos Aires. Aphria and ABP, in close partnership with the Argentinean government, continue to advance opportunities for medical cannabis in the country, including the potential for in-country cultivation.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities